Due to the COVID-19 pandemic impact on LLS fundraising activities, the Specialized Center of Research Program will not be open for submission of new applications in 2020.

2019-2020 LOI and Full Application Guidelines & Instructions

Policies and Procedures

SCOR Grant Terms (updated February 2020)

Award

A SCOR team will be judged as a unit and funding will not be available for otherwise meritorious but non-synergistic parts of an application. The quality and significance of the Projects and Cores, and the enhanced productivity that is likely to be achieved by linking the investigators, are the primary determinants of funding decisions.

Each SCOR is comprised of a minimum of three scientific Projects and a minimum of two scientific Cores that will cooperate under the leadership of a SCOR Director. There must be objective evidence of interdisciplinary research among the Projects and Cores.

The maximal annual total cost is $1,000,000 for each year of the five year grant. The maximum annual direct cost is $833,333.33 while the maximum annual indirect cost is $166,666.66. The SCOR Director has the authority to budget these funds among the various Projects and Cores.

How to Apply/Deadlines

LLS uses its own Research Portal powered by FLUXX for Letter of Intent (LOI) and full application submission.

Application Timeline

Mission Score

During the review process, in addition to a Priority Score, each application will be assigned a Mission Score, which evaluates the alignment of the proposal with the intention of the award mechanism; it does not evaluate the scientific/clinical quality of the research. Though the Priority Score is the most prominent for funding decisions, the Mission Score may be used to distinguish between two applications with similar Priority Scores. For example, an application with a Mission Score of 1 may be funded over an application with the same/similar Priority Score, but with a Mission Score of 3.

Mission Score of 1: There is a very high degree of integration between basic and translational research with strong potential to lead to a clinical trial during the duration of the award.

Mission Score of 2: There is a very high degree of integration between basic and translational research with a moderate potential to lead to a clinical trial during the duration of the award.

Mission Score of 3: There is a moderate degree of integration between basic and translational research with a limited potential to lead to a clinical trial during the duration of the award.

SCOR Application FAQ

How do I complete the budget section on the application?

How will awarded funding be dispersed, and what costs are permitted?

How can I verify that a submission was successful?

How do I add the names of the administrators at my institution to my application?

Is there a particular naming convention that applicants should use for the Full Application Document?

When should biosketches be uploaded throughout the application process?

Which institutions are eligible for the SCOR program?

When are organizational assurances required, and what is required for these?

Can applicants delete instructions from the template to make more space?

Is there a salary cap?

How often should Project and Core Leaders meet/communicate with each other?

Is the Letter of Intent phase competitive?

Need More Information?

Contact:

Senior Director of Research Administration
The Leukemia & Lymphoma Society
3 International Drive, Suite 200
Rye Brook, NY 10573

researchprograms@lls.org